Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Memory | 39 | 2018 | 187 | 12.760 |
Why?
|
Drosophila Proteins | 35 | 2018 | 43 | 9.330 |
Why?
|
Drosophila melanogaster | 32 | 2018 | 38 | 8.810 |
Why?
|
Mushroom Bodies | 31 | 2018 | 31 | 8.470 |
Why?
|
Smell | 31 | 2018 | 46 | 8.390 |
Why?
|
Drosophila | 31 | 2017 | 34 | 7.200 |
Why?
|
Neurons | 30 | 2018 | 394 | 6.720 |
Why?
|
Olfactory Pathways | 13 | 2018 | 16 | 3.470 |
Why?
|
Conditioning, Classical | 17 | 2018 | 24 | 3.410 |
Why?
|
Learning | 11 | 2017 | 76 | 3.290 |
Why?
|
Animals | 78 | 2018 | 7300 | 3.110 |
Why?
|
Memory Disorders | 10 | 2017 | 61 | 2.830 |
Why?
|
Avoidance Learning | 7 | 2018 | 18 | 2.730 |
Why?
|
Synapses | 10 | 2018 | 85 | 2.460 |
Why?
|
Animals, Genetically Modified | 25 | 2018 | 67 | 2.330 |
Why?
|
Olfactory Perception | 5 | 2018 | 10 | 2.210 |
Why?
|
Brain | 15 | 2018 | 930 | 1.970 |
Why?
|
MicroRNAs | 4 | 2016 | 173 | 1.900 |
Why?
|
Aging | 6 | 2018 | 881 | 1.690 |
Why?
|
Behavior, Animal | 16 | 2018 | 264 | 1.550 |
Why?
|
Transcription Factors | 12 | 2016 | 172 | 1.360 |
Why?
|
Synaptic Transmission | 7 | 2016 | 113 | 1.340 |
Why?
|
Olfactory Receptor Neurons | 6 | 2016 | 7 | 1.240 |
Why?
|
Nerve Tissue Proteins | 3 | 2018 | 118 | 1.200 |
Why?
|
Cyclic AMP | 6 | 2018 | 40 | 1.200 |
Why?
|
Neuronal Plasticity | 7 | 2015 | 81 | 1.060 |
Why?
|
Nuclear Proteins | 2 | 2018 | 71 | 0.920 |
Why?
|
Calcium | 9 | 2016 | 297 | 0.860 |
Why?
|
Hippocampus | 4 | 2012 | 185 | 0.820 |
Why?
|
Nerve Net | 4 | 2017 | 115 | 0.820 |
Why?
|
Synaptic Vesicles | 2 | 2018 | 7 | 0.820 |
Why?
|
Models, Animal | 3 | 2018 | 160 | 0.810 |
Why?
|
Gene Expression Profiling | 4 | 2018 | 320 | 0.810 |
Why?
|
Association Learning | 4 | 2009 | 16 | 0.780 |
Why?
|
Gene Expression Regulation | 9 | 2016 | 481 | 0.760 |
Why?
|
Dopamine | 6 | 2017 | 226 | 0.740 |
Why?
|
Microscopy, Confocal | 2 | 2018 | 62 | 0.740 |
Why?
|
Receptors, Dopamine D1 | 2 | 2017 | 19 | 0.740 |
Why?
|
Memory, Short-Term | 2 | 2018 | 59 | 0.730 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2017 | 179 | 0.730 |
Why?
|
Signal Transduction | 6 | 2016 | 666 | 0.680 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 11 | 0.670 |
Why?
|
Histone Acetyltransferases | 2 | 2018 | 5 | 0.660 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 58 | 0.660 |
Why?
|
Receptors, GABA-A | 2 | 2009 | 32 | 0.650 |
Why?
|
Receptors, Dopamine | 1 | 2017 | 20 | 0.630 |
Why?
|
Neuropeptides | 5 | 2012 | 19 | 0.620 |
Why?
|
Neurogenesis | 1 | 2017 | 14 | 0.620 |
Why?
|
Granulocytes | 1 | 2017 | 12 | 0.610 |
Why?
|
BCG Vaccine | 1 | 2017 | 7 | 0.610 |
Why?
|
Feedback | 1 | 2017 | 33 | 0.600 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2016 | 10 | 0.600 |
Why?
|
Putamen | 1 | 2016 | 25 | 0.590 |
Why?
|
Caudate Nucleus | 1 | 2016 | 23 | 0.590 |
Why?
|
Cation Transport Proteins | 1 | 2016 | 24 | 0.580 |
Why?
|
Mutation | 6 | 2011 | 466 | 0.570 |
Why?
|
Organic Cation Transport Proteins | 1 | 2016 | 1 | 0.570 |
Why?
|
Cholinergic Fibers | 1 | 2016 | 7 | 0.570 |
Why?
|
Data Interpretation, Statistical | 3 | 2012 | 103 | 0.540 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 68 | 0.540 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2012 | 155 | 0.530 |
Why?
|
rac GTP-Binding Proteins | 2 | 2016 | 2 | 0.520 |
Why?
|
Trans-Activators | 3 | 2004 | 47 | 0.510 |
Why?
|
Protein Biosynthesis | 1 | 2015 | 46 | 0.510 |
Why?
|
Time Factors | 10 | 2015 | 2001 | 0.500 |
Why?
|
Membrane Proteins | 1 | 2016 | 256 | 0.500 |
Why?
|
Sleep | 1 | 2015 | 87 | 0.500 |
Why?
|
gamma-Aminobutyric Acid | 3 | 2010 | 74 | 0.500 |
Why?
|
Burns | 2 | 2012 | 97 | 0.490 |
Why?
|
Armadillo Domain Proteins | 1 | 2013 | 1 | 0.480 |
Why?
|
Polyamines | 1 | 2013 | 10 | 0.470 |
Why?
|
Neuroprotective Agents | 1 | 2013 | 20 | 0.470 |
Why?
|
Electroshock | 5 | 2016 | 18 | 0.470 |
Why?
|
Autophagy | 1 | 2013 | 53 | 0.460 |
Why?
|
Appetite Regulation | 1 | 2012 | 2 | 0.440 |
Why?
|
Gene Expression Regulation, Developmental | 6 | 2016 | 68 | 0.430 |
Why?
|
Female | 16 | 2018 | 18173 | 0.430 |
Why?
|
Models, Statistical | 2 | 2012 | 163 | 0.430 |
Why?
|
Multiple Sclerosis | 1 | 2012 | 43 | 0.410 |
Why?
|
Carrier Proteins | 2 | 2016 | 131 | 0.410 |
Why?
|
Axons | 2 | 2016 | 24 | 0.410 |
Why?
|
Mice | 9 | 2018 | 2371 | 0.410 |
Why?
|
Dynamins | 2 | 2012 | 2 | 0.400 |
Why?
|
Saccharomyces cerevisiae Proteins | 6 | 2008 | 15 | 0.400 |
Why?
|
Bone Density | 2 | 2010 | 182 | 0.390 |
Why?
|
Green Fluorescent Proteins | 5 | 2012 | 71 | 0.390 |
Why?
|
Casein Kinase I | 1 | 2010 | 1 | 0.390 |
Why?
|
Space Perception | 2 | 2008 | 26 | 0.390 |
Why?
|
Gene Knockdown Techniques | 3 | 2018 | 73 | 0.380 |
Why?
|
Transgenes | 6 | 2013 | 45 | 0.380 |
Why?
|
Neurofibromatosis 1 | 1 | 2010 | 9 | 0.380 |
Why?
|
Conditioning, Operant | 2 | 2011 | 96 | 0.370 |
Why?
|
Vibration | 1 | 2010 | 10 | 0.370 |
Why?
|
Long-Term Potentiation | 2 | 2007 | 21 | 0.370 |
Why?
|
Spinal Cord Injuries | 1 | 2010 | 32 | 0.360 |
Why?
|
Osteoporosis | 1 | 2010 | 51 | 0.350 |
Why?
|
Male | 16 | 2018 | 17815 | 0.340 |
Why?
|
Gene Expression | 2 | 2015 | 332 | 0.330 |
Why?
|
Orientation | 1 | 2008 | 24 | 0.330 |
Why?
|
Humans | 18 | 2018 | 29123 | 0.320 |
Why?
|
Circadian Rhythm | 1 | 2008 | 43 | 0.320 |
Why?
|
Integrin alpha3 | 1 | 2007 | 1 | 0.310 |
Why?
|
Action Potentials | 2 | 2005 | 174 | 0.300 |
Why?
|
Pheromones | 1 | 2007 | 3 | 0.300 |
Why?
|
Sexual Behavior, Animal | 1 | 2007 | 9 | 0.300 |
Why?
|
Gender Identity | 1 | 2007 | 18 | 0.300 |
Why?
|
Drug Tolerance | 1 | 2007 | 36 | 0.300 |
Why?
|
RNA, Messenger | 3 | 2005 | 514 | 0.300 |
Why?
|
Promoter Regions, Genetic | 2 | 2004 | 212 | 0.290 |
Why?
|
Luminescent Proteins | 2 | 2003 | 24 | 0.290 |
Why?
|
Central Nervous System Depressants | 1 | 2007 | 63 | 0.290 |
Why?
|
Mitochondria | 2 | 2018 | 174 | 0.280 |
Why?
|
Receptors, AMPA | 1 | 2006 | 14 | 0.280 |
Why?
|
RNA Probes | 1 | 2005 | 4 | 0.280 |
Why?
|
Cells, Cultured | 4 | 2018 | 799 | 0.270 |
Why?
|
Motor Activity | 2 | 2005 | 310 | 0.260 |
Why?
|
Neural Pathways | 1 | 2005 | 97 | 0.260 |
Why?
|
Central Nervous System | 1 | 2005 | 29 | 0.260 |
Why?
|
Vision, Ocular | 1 | 2005 | 30 | 0.260 |
Why?
|
Neurosciences | 1 | 2005 | 8 | 0.260 |
Why?
|
Neutrophils | 2 | 2017 | 102 | 0.260 |
Why?
|
Ethanol | 1 | 2007 | 185 | 0.250 |
Why?
|
DNA-Binding Proteins | 5 | 2008 | 142 | 0.250 |
Why?
|
Electric Stimulation | 3 | 2010 | 102 | 0.250 |
Why?
|
Mice, Knockout | 6 | 2012 | 425 | 0.250 |
Why?
|
Gene Targeting | 1 | 2004 | 17 | 0.240 |
Why?
|
Enhancer Elements, Genetic | 2 | 2008 | 16 | 0.240 |
Why?
|
Research Design | 1 | 2005 | 286 | 0.240 |
Why?
|
Analysis of Variance | 4 | 2012 | 454 | 0.240 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2003 | 14 | 0.240 |
Why?
|
Integrins | 1 | 2003 | 20 | 0.230 |
Why?
|
Image Enhancement | 1 | 2003 | 70 | 0.230 |
Why?
|
Appetitive Behavior | 2 | 2014 | 6 | 0.230 |
Why?
|
Pattern Recognition, Automated | 1 | 2003 | 34 | 0.230 |
Why?
|
Repressor Proteins | 3 | 2012 | 53 | 0.220 |
Why?
|
Amino Acid Sequence | 2 | 2018 | 280 | 0.220 |
Why?
|
Imaging, Three-Dimensional | 1 | 2003 | 130 | 0.220 |
Why?
|
Eye | 1 | 2002 | 15 | 0.220 |
Why?
|
Cell Nucleus | 1 | 2003 | 105 | 0.220 |
Why?
|
Phenotype | 6 | 2008 | 629 | 0.210 |
Why?
|
Age Factors | 3 | 2018 | 1108 | 0.210 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2003 | 113 | 0.210 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 242 | 0.210 |
Why?
|
Models, Biological | 3 | 2012 | 373 | 0.200 |
Why?
|
Base Sequence | 2 | 2016 | 240 | 0.200 |
Why?
|
Molecular Sequence Data | 2 | 2016 | 350 | 0.190 |
Why?
|
Genes, Insect | 3 | 2005 | 4 | 0.190 |
Why?
|
Algorithms | 1 | 2003 | 462 | 0.180 |
Why?
|
Ion Channels | 2 | 2012 | 24 | 0.170 |
Why?
|
Dendrites | 2 | 2016 | 15 | 0.170 |
Why?
|
Oxidative Phosphorylation | 1 | 2018 | 22 | 0.170 |
Why?
|
Cellulose, Oxidized | 1 | 2018 | 3 | 0.170 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2018 | 5 | 0.170 |
Why?
|
Sucrose | 2 | 2012 | 17 | 0.170 |
Why?
|
Hemostatics | 1 | 2018 | 12 | 0.170 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 35 | 0.170 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 26 | 0.170 |
Why?
|
Hemostasis, Surgical | 1 | 2018 | 13 | 0.170 |
Why?
|
Blood Loss, Surgical | 1 | 2018 | 45 | 0.170 |
Why?
|
Drug Discovery | 1 | 2018 | 30 | 0.170 |
Why?
|
Temperature | 2 | 2012 | 55 | 0.170 |
Why?
|
Staining and Labeling | 1 | 2018 | 56 | 0.160 |
Why?
|
Equipment Design | 1 | 2018 | 167 | 0.160 |
Why?
|
Protein Binding | 2 | 2016 | 199 | 0.160 |
Why?
|
Second Messenger Systems | 1 | 2018 | 6 | 0.160 |
Why?
|
Electrophysiology | 3 | 2007 | 66 | 0.160 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2017 | 3 | 0.160 |
Why?
|
Surgical Procedures, Operative | 1 | 2018 | 74 | 0.160 |
Why?
|
Molecular Imaging | 1 | 2018 | 22 | 0.160 |
Why?
|
RNA, Small Interfering | 2 | 2016 | 109 | 0.150 |
Why?
|
Nervous System | 2 | 2008 | 15 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2017 | 19 | 0.150 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 89 | 0.150 |
Why?
|
Larva | 3 | 2008 | 4 | 0.150 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2016 | 8 | 0.150 |
Why?
|
Bipolar Disorder | 1 | 2016 | 15 | 0.150 |
Why?
|
Neuropil | 1 | 2016 | 2 | 0.150 |
Why?
|
Schizophrenia | 1 | 2016 | 38 | 0.150 |
Why?
|
Sex Factors | 1 | 2018 | 631 | 0.150 |
Why?
|
Cell Size | 1 | 2016 | 32 | 0.150 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2017 | 65 | 0.140 |
Why?
|
Cofilin 1 | 1 | 2016 | 1 | 0.140 |
Why?
|
Genes, Suppressor | 1 | 2016 | 2 | 0.140 |
Why?
|
Gene Silencing | 1 | 2016 | 49 | 0.140 |
Why?
|
Mifepristone | 3 | 2008 | 6 | 0.140 |
Why?
|
Genes, Switch | 2 | 2008 | 2 | 0.140 |
Why?
|
RNA Interference | 1 | 2016 | 76 | 0.140 |
Why?
|
Mice, Inbred C57BL | 4 | 2012 | 711 | 0.140 |
Why?
|
Cues | 1 | 2016 | 67 | 0.140 |
Why?
|
Models, Theoretical | 1 | 2017 | 126 | 0.140 |
Why?
|
RNA | 1 | 2016 | 88 | 0.140 |
Why?
|
Maze Learning | 2 | 2007 | 17 | 0.140 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 18 | 0.140 |
Why?
|
Cytokines | 1 | 2017 | 243 | 0.140 |
Why?
|
Sense Organs | 2 | 2005 | 2 | 0.130 |
Why?
|
GABA Agonists | 1 | 2015 | 2 | 0.130 |
Why?
|
Isoxazoles | 1 | 2015 | 4 | 0.130 |
Why?
|
Arousal | 1 | 2015 | 19 | 0.130 |
Why?
|
Urinary Bladder | 1 | 2017 | 165 | 0.130 |
Why?
|
Olfactory Bulb | 2 | 2005 | 4 | 0.130 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 681 | 0.130 |
Why?
|
Caspase 3 | 1 | 2014 | 30 | 0.130 |
Why?
|
Chemotaxis | 1 | 2014 | 23 | 0.120 |
Why?
|
Rats | 1 | 2018 | 1604 | 0.120 |
Why?
|
Aged | 6 | 2018 | 9492 | 0.120 |
Why?
|
Status Epilepticus | 1 | 2013 | 22 | 0.120 |
Why?
|
Lymphocytes | 1 | 2013 | 53 | 0.110 |
Why?
|
Cloning, Molecular | 2 | 2003 | 74 | 0.110 |
Why?
|
Treatment Outcome | 2 | 2018 | 3101 | 0.110 |
Why?
|
Genetic Vectors | 2 | 2004 | 118 | 0.110 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2012 | 3 | 0.110 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 189 | 0.110 |
Why?
|
Interferon-beta | 1 | 2012 | 23 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2012 | 45 | 0.110 |
Why?
|
TRPC Cation Channels | 1 | 2012 | 2 | 0.110 |
Why?
|
Biophysics | 1 | 2012 | 9 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 1079 | 0.110 |
Why?
|
Cystectomy | 1 | 2013 | 102 | 0.110 |
Why?
|
Cadherins | 1 | 2012 | 24 | 0.110 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2012 | 22 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 546 | 0.110 |
Why?
|
Appetite | 1 | 2012 | 19 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 836 | 0.110 |
Why?
|
Disease Models, Animal | 1 | 2016 | 980 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2012 | 72 | 0.100 |
Why?
|
Middle Aged | 5 | 2018 | 10834 | 0.100 |
Why?
|
Receptors, Odorant | 2 | 2014 | 2 | 0.100 |
Why?
|
Intracellular Calcium-Sensing Proteins | 1 | 2010 | 1 | 0.100 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2010 | 5 | 0.100 |
Why?
|
CREB-Binding Protein | 1 | 2010 | 4 | 0.100 |
Why?
|
Calcium Signaling | 1 | 2011 | 40 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 129 | 0.100 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 787 | 0.090 |
Why?
|
Spine | 1 | 2010 | 38 | 0.090 |
Why?
|
Posture | 1 | 2010 | 53 | 0.090 |
Why?
|
Ureteral Calculi | 1 | 2009 | 6 | 0.090 |
Why?
|
Absorptiometry, Photon | 1 | 2010 | 129 | 0.090 |
Why?
|
Hot Temperature | 2 | 2006 | 71 | 0.090 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2009 | 19 | 0.090 |
Why?
|
Kidney Calculi | 1 | 2009 | 25 | 0.090 |
Why?
|
Blotting, Western | 2 | 2012 | 281 | 0.090 |
Why?
|
Intracellular Membranes | 1 | 2008 | 10 | 0.090 |
Why?
|
Microscopy, Fluorescence | 2 | 2012 | 81 | 0.080 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 6 | 0.080 |
Why?
|
Locomotion | 1 | 2008 | 31 | 0.080 |
Why?
|
Down-Regulation | 1 | 2008 | 143 | 0.080 |
Why?
|
Nerve Growth Factors | 1 | 2007 | 18 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 1 | 2007 | 33 | 0.080 |
Why?
|
Prosencephalon | 1 | 2007 | 5 | 0.080 |
Why?
|
Swimming | 1 | 2007 | 7 | 0.080 |
Why?
|
Motor Skills | 1 | 2007 | 12 | 0.080 |
Why?
|
Muscles | 2 | 2008 | 53 | 0.080 |
Why?
|
Microscopy, Electron | 1 | 2007 | 25 | 0.080 |
Why?
|
Diphosphonates | 1 | 2007 | 9 | 0.080 |
Why?
|
Gene Deletion | 1 | 2007 | 64 | 0.080 |
Why?
|
Bone Density Conservation Agents | 1 | 2007 | 20 | 0.080 |
Why?
|
Androgen Antagonists | 1 | 2007 | 15 | 0.080 |
Why?
|
Models, Neurological | 1 | 2008 | 115 | 0.080 |
Why?
|
Drug Resistance | 1 | 2007 | 36 | 0.070 |
Why?
|
Cycloheximide | 1 | 2006 | 7 | 0.070 |
Why?
|
Arrestins | 1 | 2006 | 3 | 0.070 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2006 | 12 | 0.070 |
Why?
|
Imidazoles | 1 | 2007 | 104 | 0.070 |
Why?
|
Psychomotor Performance | 1 | 2007 | 97 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2010 | 327 | 0.070 |
Why?
|
Exploratory Behavior | 1 | 2006 | 30 | 0.070 |
Why?
|
Adult | 4 | 2018 | 8426 | 0.070 |
Why?
|
Body Mass Index | 1 | 2010 | 865 | 0.070 |
Why?
|
Arrestin | 1 | 2005 | 1 | 0.070 |
Why?
|
Photoreceptor Cells, Invertebrate | 1 | 2005 | 1 | 0.070 |
Why?
|
Fixatives | 1 | 2005 | 3 | 0.070 |
Why?
|
Poly(A)-Binding Proteins | 1 | 2005 | 2 | 0.070 |
Why?
|
Formaldehyde | 1 | 2005 | 11 | 0.070 |
Why?
|
Genotype | 2 | 2006 | 735 | 0.070 |
Why?
|
Embryonic Development | 1 | 2005 | 9 | 0.070 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2005 | 12 | 0.070 |
Why?
|
Oligopeptides | 1 | 2005 | 51 | 0.070 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 51 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2005 | 82 | 0.070 |
Why?
|
Receptors, Purinergic P2 | 1 | 2005 | 8 | 0.070 |
Why?
|
Protein-Serine-Threonine Kinases | 1 | 2005 | 44 | 0.070 |
Why?
|
Ion Channel Gating | 1 | 2005 | 19 | 0.070 |
Why?
|
Lasers | 1 | 2005 | 19 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 97 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2005 | 54 | 0.070 |
Why?
|
TRPV Cation Channels | 1 | 2005 | 19 | 0.070 |
Why?
|
Life Style | 1 | 2007 | 364 | 0.060 |
Why?
|
Peptides | 1 | 2005 | 118 | 0.060 |
Why?
|
DNA Nucleotidyltransferases | 1 | 2004 | 1 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2004 | 56 | 0.060 |
Why?
|
Recruitment, Neurophysiological | 1 | 2004 | 2 | 0.060 |
Why?
|
Models, Molecular | 1 | 2005 | 178 | 0.060 |
Why?
|
5' Flanking Region | 1 | 2004 | 1 | 0.060 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2004 | 23 | 0.060 |
Why?
|
Receptors, Biogenic Amine | 1 | 2003 | 1 | 0.060 |
Why?
|
Receptors, Neurotransmitter | 1 | 2003 | 3 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2003 | 7 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2004 | 42 | 0.060 |
Why?
|
Ovulation | 1 | 2003 | 6 | 0.060 |
Why?
|
Pharmacogenetics | 1 | 2003 | 35 | 0.060 |
Why?
|
Differential Threshold | 1 | 2003 | 1 | 0.060 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2003 | 2 | 0.060 |
Why?
|
Protein Subunits | 1 | 2003 | 34 | 0.060 |
Why?
|
Heterozygote | 1 | 2003 | 52 | 0.060 |
Why?
|
Myosin Heavy Chains | 1 | 2004 | 86 | 0.060 |
Why?
|
Fear | 1 | 2003 | 44 | 0.060 |
Why?
|
Purkinje Cells | 1 | 2003 | 2 | 0.060 |
Why?
|
Cerebellar Cortex | 1 | 2003 | 4 | 0.060 |
Why?
|
Indicators and Reagents | 1 | 2003 | 15 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2003 | 66 | 0.060 |
Why?
|
Potassium | 1 | 2003 | 37 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 248 | 0.060 |
Why?
|
Calcium Channel Blockers | 1 | 2003 | 49 | 0.060 |
Why?
|
Ricin | 1 | 2002 | 4 | 0.060 |
Why?
|
Acetylcholine | 1 | 2003 | 47 | 0.060 |
Why?
|
DNA Transposable Elements | 1 | 2002 | 14 | 0.060 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 441 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2003 | 77 | 0.050 |
Why?
|
Infant | 2 | 2013 | 969 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2018 | 165 | 0.040 |
Why?
|
Child, Preschool | 2 | 2013 | 1167 | 0.040 |
Why?
|
Young Adult | 2 | 2018 | 2402 | 0.040 |
Why?
|
Prognosis | 2 | 2013 | 1362 | 0.040 |
Why?
|
Administration, Intravesical | 1 | 2017 | 22 | 0.040 |
Why?
|
Oncolytic Viruses | 1 | 2017 | 10 | 0.040 |
Why?
|
Adenoviridae | 1 | 2017 | 61 | 0.040 |
Why?
|
Child | 2 | 2013 | 2219 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2010 | 1362 | 0.030 |
Why?
|
Malus | 1 | 2014 | 9 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2006 | 519 | 0.030 |
Why?
|
Preoperative Period | 1 | 2013 | 31 | 0.030 |
Why?
|
Brain Mapping | 1 | 2014 | 182 | 0.030 |
Why?
|
Prospective Studies | 1 | 2018 | 2021 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2012 | 32 | 0.030 |
Why?
|
Microscopy, Immunoelectron | 1 | 2012 | 8 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2012 | 103 | 0.030 |
Why?
|
Apoptosis | 1 | 2014 | 337 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 152 | 0.030 |
Why?
|
Cell Line | 1 | 2012 | 450 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 709 | 0.030 |
Why?
|
Survival Rate | 1 | 2013 | 795 | 0.020 |
Why?
|
Genes, Mitochondrial | 1 | 2010 | 2 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 2010 | 5 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2010 | 35 | 0.020 |
Why?
|
Software | 1 | 2010 | 109 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2017 | 3719 | 0.020 |
Why?
|
Glue Proteins, Drosophila | 1 | 2009 | 1 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 11 | 0.020 |
Why?
|
North Carolina | 1 | 2013 | 1423 | 0.020 |
Why?
|
Risk | 1 | 2009 | 289 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2008 | 14 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2013 | 2109 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2010 | 721 | 0.020 |
Why?
|
Neuroglia | 1 | 2008 | 29 | 0.020 |
Why?
|
Motor Neurons | 1 | 2008 | 53 | 0.020 |
Why?
|
Neurons, Afferent | 1 | 2008 | 54 | 0.020 |
Why?
|
Neuromuscular Junction | 1 | 2008 | 67 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2006 | 35 | 0.020 |
Why?
|
Physical Stimulation | 1 | 2006 | 84 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2005 | 33 | 0.020 |
Why?
|
Homozygote | 1 | 2005 | 57 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2013 | 3112 | 0.020 |
Why?
|
Octopamine | 1 | 2003 | 1 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2003 | 37 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2003 | 55 | 0.010 |
Why?
|
Infertility, Female | 1 | 2003 | 27 | 0.010 |
Why?
|
Ovary | 1 | 2003 | 54 | 0.010 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2003 | 3 | 0.010 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2003 | 3 | 0.010 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2003 | 4 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 165 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2003 | 436 | 0.010 |
Why?
|
Stem Cells | 1 | 2003 | 292 | 0.010 |
Why?
|